FSA Wealth Management LLC Makes New $65,000 Investment in iShares Biotechnology ETF (NASDAQ:IBB)

FSA Wealth Management LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 447 shares of the financial services provider’s stock, valued at approximately $65,000.

Several other institutional investors also recently modified their holdings of the company. Williams Financial LLC acquired a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth approximately $867,000. PVG Asset Management Corp acquired a new position in shares of iShares Biotechnology ETF in the second quarter valued at $415,000. Huntington National Bank raised its position in shares of iShares Biotechnology ETF by 17.9% in the third quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after purchasing an additional 160 shares during the period. Concourse Financial Group Securities Inc. lifted its stake in shares of iShares Biotechnology ETF by 22.4% during the 2nd quarter. Concourse Financial Group Securities Inc. now owns 656 shares of the financial services provider’s stock worth $90,000 after buying an additional 120 shares during the last quarter. Finally, Raymond James & Associates boosted its holdings in shares of iShares Biotechnology ETF by 4.4% during the 2nd quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock worth $26,047,000 after buying an additional 7,931 shares during the period. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 0.0 %

Shares of IBB opened at $141.55 on Monday. iShares Biotechnology ETF has a 52 week low of $119.95 and a 52 week high of $150.57. The firm’s 50-day simple moving average is $142.71 and its 200 day simple moving average is $142.06.

iShares Biotechnology ETF Announces Dividend

The company also recently declared a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.